©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Urol. Nov 24, 2014; 3(3): 195-200
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.195
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.195
From the battlefield to the bladder: The development of thioTEPA
Sean M Gallagher, Steven H Selman, Department of Urology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, United States
Steven H Selman, Department of Urology, University of Toledo Medical Center, Toledo, OH 43614, United States
Author contributions: Gallagher SM and Selman SH contributed equally to the conception, research, composition and editing of this manuscript.
Supported by The Frank D Stranahan Endowment for Oncologic Research
Correspondence to: Steven H Selman, MD, Department of Urology, University of Toledo Medical Center, 3000 Arlington Ave., Toledo, OH 43614, United States. sean.gallagher@rockets.utoledo.edu
Telephone: +1-419-3833584 Fax: +1-419-3833785
Received: April 24, 2014
Revised: July 31, 2014
Accepted: August 27, 2014
Published online: November 24, 2014
Processing time: 208 Days and 18.3 Hours
Revised: July 31, 2014
Accepted: August 27, 2014
Published online: November 24, 2014
Processing time: 208 Days and 18.3 Hours
Core Tip
Core tip: We attempt to outline the lineage of intravesical chemotherapy. Specifically, we look at its relationship to poisonous gas used in wartime and chronicle its journey to the bedside.